Related Experiment Video
Updated: Feb 8, 2026
11:27
Synthesis and Characterization of Functionalized Metal-organic Frameworks
Published on: September 5, 2014
49.2K
Metal-Organic Frameworks as Efficient Oral Detoxifying Agents
Sara Rojas1, Tarek Baati1,2, Leila Njim3
1Institut Lavoisier, CNRS UMR 8180, UVSQ , Université Paris-Saclay , 45 Av. Des Etats Unis , Versailles 78035 Cedex , France.
Journal of the American Chemical Society
|July 11, 2018
Summary
A novel biocompatible metal-organic framework (MOF) shows promise as an oral detoxifying agent. This adsorbent significantly reduces salicylate absorption and toxicity, offering a safer treatment for poisoning.
Area of Science:
- Materials Science
- Toxicology
- Pharmacology
Background:
- Poisoning and accidental oral intoxication pose significant global health challenges.
- Current detoxification treatments often exhibit insufficient efficacy.
- There is a need for advanced oral adsorbent agents for poisoning management.
Purpose of the Study:
- To develop and evaluate a novel biocompatible metal-organic framework (MOF) as an oral detoxifying adsorbent agent.
- To investigate the in vivo toxicity and biodistribution of the MOF following oral administration for the first time.
- To assess the MOF's efficacy in reducing gastrointestinal absorption and toxicity of common poisoning agents, specifically salicylate.
Main Methods:
- Synthesis and characterization of a biocompatible metal-organic framework (MOF).
- In vitro assessment of MOF's gastrointestinal stability and drug adsorption capacity.
- In vivo studies in animal models to evaluate MOF's efficacy in reducing salicylate absorption and toxicity after oral administration.
- Toxicological evaluation including biodistribution studies of the orally administered MOF.
Main Results:
- The developed MOF demonstrated exceptional gastrointestinal stability with less than 9% degradation.
- Oral administration of the MOF significantly reduced salicylate gastrointestinal absorption and toxicity by over 40-fold.
- The MOF exhibited poor intestinal permeation and a favorable safety profile in vivo.
- Histological damage associated with salicylate overdose was effectively avoided by MOF treatment.
Conclusions:
- This pioneering biocompatible metal-organic framework (MOF) presents a highly effective and safe oral adsorbent for managing poisoning.
- The MOF's ability to significantly reduce drug absorption and toxicity, coupled with its stability and safety, marks a breakthrough in detoxification strategies.
- Further research into MOF-based adsorbents holds great potential for advancing the treatment of poisoning and intoxication.
More Related Videos
Related Concept Videos
01:06Oral Hypoglycemic Agents: Glinides
680
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
680
01:17Oral Hypoglycemic Agents: Sulfonylureas
1.1K
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
1.1K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
680
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
680
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
583
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
583
00:49Gravimetry: Inorganic And Organic Precipitating Agents
7.1K
In gravimetry, the precipitant is chosen carefully to obtain a pure solid that can be easily filtered. Common inorganic precipitants can be used to determine several cations and anions. In some cases, the formation of the same precipitate can be used to determine the cation and the anion. For example, the reaction of barium and chromate ions to give barium chromate is used to determine both barium and chromate. However, precipitates such as hydroxides, oxalates, and metal ammonium phosphates...
7.1K
03:06Alkali Metals
24.9K
Group 1 elements are soft and shiny metallic solids. They are malleable, ductile, and good conductors of heat and electricity. The melting points of the alkali metals are unusually low for metals and decrease going down the group, while the density increases going down the group with the exception of potassium (Table 1).
Table 1: Properties of the alkali metals
Table 1: Properties of the alkali metals
24.9K